HM Payson & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100
| Closed | -$9.88K | – | 1160 |
|
|
2024
Q3 | $9.88K | Buy |
+100
| New | +$9.88K | ﹤0.01% | 837 |
|
|
2024
Q2 | – | Sell |
-271
| Closed | -$25.7K | – | 1037 |
|
|
2024
Q1 | $25.7K | Sell |
271
-129
| -32% | -$12.2K | ﹤0.01% | 706 |
|
|
2023
Q4 | $35.7K | Hold |
400
| – | – | ﹤0.01% | 644 |
|
|
2023
Q3 | $29.2K | Hold |
400
| – | – | ﹤0.01% | 677 |
|
|
2023
Q2 | $33.3K | Sell |
400
-414
| -51% | -$34.4K | ﹤0.01% | 652 |
|
|
2023
Q1 | $62K | Hold |
814
| – | – | ﹤0.01% | 538 |
|
|
2022
Q4 | $67.6K | Sell |
814
-1,456
| -64% | -$121K | ﹤0.01% | 520 |
|
|
2022
Q3 | $180K | Hold |
2,270
| – | – | ﹤0.01% | 391 |
|
|
2022
Q2 | $169K | Hold |
2,270
| – | – | ﹤0.01% | 403 |
|
|
2022
Q1 | $204K | Hold |
2,270
| – | – | ﹤0.01% | 400 |
|
|
2021
Q4 | $254K | Hold |
2,270
| – | – | 0.01% | 372 |
|
|
2021
Q3 | $285K | Hold |
2,270
| – | – | 0.01% | 334 |
|
|
2021
Q2 | $307K | Hold |
2,270
| – | – | 0.01% | 335 |
|
|
2021
Q1 | $308K | Buy |
2,270
+12
| +0.5% | +$1.63K | 0.01% | 327 |
|
|
2020
Q4 | $318K | Hold |
2,258
| – | – | 0.01% | 324 |
|
|
2020
Q3 | $252K | Buy |
2,258
+333
| +17% | +$37.2K | 0.01% | 327 |
|
|
2020
Q2 | $216K | Hold |
1,925
| – | – | 0.01% | 332 |
|
|
2020
Q1 | $149K | Sell |
1,925
-127
| -6% | -$9.83K | 0.01% | 362 |
|
|
2019
Q4 | $195K | Sell |
2,052
-250
| -11% | -$23.8K | 0.01% | 391 |
|
|
2019
Q3 | $176K | Hold |
2,302
| – | – | 0.01% | 404 |
|
|
2019
Q2 | $202K | Buy |
+2,302
| New | +$202K | 0.01% | 391 |
|
|
2015
Q3 | – | Sell |
-2,679
| Closed | -$225K | – | 311 |
|
|
2015
Q2 | $225K | Hold |
2,679
| – | – | 0.01% | 280 |
|
|
2015
Q1 | $201K | Buy |
+2,679
| New | +$201K | 0.01% | 289 |
|